The Express TribuneOntario's first cardiac stem cell transplant performed last weekMedical XpressAs part of the ongoing IMPACT-CABG clinical trial to treat advanced heart failure, physicians at the Peter Munk Cardiac Centre performed the first card…
The Zacks Analyst Blog Highlights: The Boeing, Lockheed Martin, Abbott Labs …NASDAQAbbott Labs, along with partner Biogen ( BIIB ), moved daclizumab into a phase III study for the treatment of relapsing-remitting multiple sclerosis ( RRMS ). Abbott L…
Ontario's First Cardiac Stem Cell Transplant Performed Last Week at the Peter …Newswise (press release)As part of the ongoing IMPACT-CABG clinical trial to treat advanced heart failure, physicians at the Peter Munk Cardiac Centre performed the fi…
System to deliver organ transplant drug — without harmful side effectsEurekAlert (press release)The drug, cyclosporine (CsA), is widely used in transplant operations and helps prevent the patient's body rejecting the organ but it can cause adverse…
The Zacks Analyst Blog Highlights: The Boeing, Lockheed Martin, Abbott Labs …PR Newswire (press release)Abbott Labs, along with partner Biogen (Nasdaq: BIIB), moved daclizumab into a phase III study for the treatment of relapsing-remitting multiple s…
Binaytara Foundation to Develop First Blood and Marrow Transplant Center in NepalSacramento BeeStem cell transplant is a standard procedure for the treatment of many blood cancers. The planned BMT center in Bharatpur will aim to serve not only the 30 m…
Risk Factors for Transplant-Related Urinary Complications CharacterizedRenal and Urology NewsThese included some parameters that have been evaluated in previous research–including donor and recipient age, donor and recipient race, and cold ischemia t…
Binaytara Foundation to Develop First Blood and Marrow Transplant Center in NepalMarketWatch (press release)Stem cell transplant is a standard procedure for the treatment of many blood cancers. The planned BMT center in Bharatpur will aim to serve not …
Hockey Moms and Dads Unite to Support Chiusano FamilyPatch.comIn and out of the hospital to receive treatments, Deana had a costly stem cell transplant in November. In support of the Chiusanos, members of the hockey organization—led by Chris Krebs…
NICE final OK extends use of MabTheraPharma TimesThe National Institute for Health and Clinical Excellence (NICE) has issued final guidance recommending Roche's MabThera (rituximab) as an option when used in combination with a wide range of chemoth…